Moreover, the triple therapy comprising ablative radiotherapy, ATR inhibition, and immune checkpoint inhibitor therapy further reduced the metastatic tumor burden (P < 0.01; Fig. 3I), indicating enhanced antitumor immunity and a potential abscopal effect. This evidence concerns the gene ATR and neoplasm.